The pharmaceutical industry's decades-long effort to find a kind of blood thinner called an anticoagulant that can help patients who have suffered a heart attack may finally have hit pay dirt, a major new study suggests.
J&J drug may have new role
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.